ULTRA-LATE (>24 WEEKS) RESPONSE TO ANTI-CGRP MONOCLONAL ANTIBODIES IN MIGRAINE: A MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY

被引：0

作者：

Aurilia, C. ^{[1
]}

Egeo, G. ^{[1
]}

Proietti, S. ^{[2
]}

Cevoli, S. ^{[3
]}

Colombo, B. ^{[4
]}

Messina, R. ^{[4
]}

Torelli, P. ^{[5
]}

D'Onofrio, F. ^{[6
]}

Vernieri, F. ^{[7
]}

Altamura, C. ^{[7
]}

Salerno, A. ^{[8
]}

Aguggia, M. ^{[9
]}

Grazzi, L. ^{[10
]}

Trimboli, M. ^{[11
]}

Mercuri, B.

Carnevale, A. ^{[12
]}

Zucco, M. ^{[13
]}

Di Clemente, L. ^{[13
]}

Albanese, M. ^{[14
]}

Finocchi, C. ^{[15
]}

Bono, F. ^{[16
]}

Frediani, F. ^{[17
]}

Filippi, M. ^{[4
]}

Bertuzzo, D.

Favoni, V

Di Fiore, P. ^{[17
]}

Bonassi, S. ^{[2
,18
]}

Barbanti, P. ^{[18
]}

机构：

[1] Headache & Pain Unit IRCCS San Raffaele Roma, Rome, Italy

[2] Clin & Mol Epidemiol IRCCS San Raffaele Roma, Rome, Italy

[3] IRCCS Ist Sci Neurol Bologna, Bologna, Italy

[4] Univ Vita Salute San Raffaele, Neurol Unit, IRCCS San Raffaele Sci Inst, Milan, Italy

[5] Univ Parma, Unit Neurol, Dept Med & Surg, Headache Ctr, Parma, Italy

[6] San Giuseppe Moscati Hosp, Headache Ctr, Neurol Unit, Avellino, Italy

[7] Policlin Univ, Headache & Neurosonol Unit, Campus Biomed, Rome, Italy

[8] San Giovanni Addolorata Hosp, Headache Ctr, Rome, Italy

[9] Headache Ctr Cardinal Massaia, Asti, Italy

[10] Fdn IRCCS Ist Neurol Carlo Besta, Headache Ctr, Neuroalgol Unit, Milan, Italy

[11] Magna Graecia Univ Catanzaro, Catanzaro, Italy

[12] San Filippo Neri Hosp, Headache Ctr, Rome, Italy

[13] San Camillo Forlanini Hosp, Headache Ctr, Rome, Italy

[14] Univ Hosp Tor Vergata, Reg Referral Headache Ctr, Neurol Unit, Rome, Italy

[15] San Paolo Hosp ASL 2 Savonese, Div Neurol, Savona, Italy

[16] AOU Mater Domini, Ctr Headache & Intracranial Pressure Disorders, Neurol Unit, Catanzaro, Italy

[17] ASST Santi Paolo Carlo, Headache Ctr, Milan, Italy

[18] San Raffaele Univ, Rome, Italy

来源：

HEADACHE | 2023年 / 63卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P-200

引用

页码：177 / 178

页数：2

共 50 条

[21] Could symptom severity predict the response to anti-CGRP monoclonal antibodies in migraine?
Membrilla, J.
Ruiz Castrillo, M.
Sastre Real, M.
Sanchez Casado, L.
Trillo Marino, E.
Corral, C.
Estebas, C.
Gonzalez Sarmiento, R.
Lorenzo, M.
Diaz de Teran, J.
EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 413 - 413
[22] Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Migraine
Hennessy, Elise
Salim, Amira
Biswas, Sudipa
Suneja, Aarushi
Mays, Maryann
Ahmed, Zubair
Mata, Ignacio
NEUROLOGY, 2023, 100 (17)
[23] Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Amy R. Tso
Peter J. Goadsby
Current Treatment Options in Neurology, 2017, 19
[24] Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Tso, Amy R.
Goadsby, Peter J.
CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2017, 19 (08)
[25] Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine
Iannone, Luigi Francesco
De Cesaris, Francesco
Ferrari, Anita
Benemei, Silvia
Fattori, Davide
Chiarugi, Alberto
CEPHALALGIA, 2022, 42 (13) : 1323 - 1330
[26] Switching between anti-CGRP monoclonal antibodies in migraine prophylaxis
Vikelis, Michail
Rikos, Dimitrios
Argyriou, Andreas A.
Dermitzakis, Emmanouil V.
Andreou, Anna P.
Russo, Antonio
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2025,
[27] Synergism of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in the treatment of migraine
Hennessy, E.
Salim, A.
Biswas, S.
Sonneborn, C.
Hogue, O.
Suneja, A.
Mays, M.
Ahmed, Z.
Mata, I
HEADACHE, 2023, 63 : 170 - 171
[28] Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study
Vernieri, Fabrizio
Brunelli, Nicoletta
Guerzoni, Simona
Iannone, Luigi Francesco
Baraldi, Carlo
Rao, Renata
di Cola, Francesca Schiano
Ornello, Raffaele
Cevoli, Sabina
Lovati, Carlo
Albanese, Maria
Perrotta, Armando
Cetta, Ilaria
Rossi, Sergio Soeren
Taranta, Valentina
Filippi, Massimo
Geppetti, Pierangelo
Sacco, Simona
Altamura, Claudia
JOURNAL OF NEUROLOGY, 2023, 270 (11) : 5436 - 5448
[29] Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study
Fabrizio Vernieri
Nicoletta Brunelli
Simona Guerzoni
Luigi Francesco Iannone
Carlo Baraldi
Renata Rao
Francesca Schiano di Cola
Raffaele Ornello
Sabina Cevoli
Carlo Lovati
Maria Albanese
Armando Perrotta
Ilaria Cetta
Sergio Soeren Rossi
Valentina Taranta
Massimo Filippi
Pierangelo Geppetti
Simona Sacco
Claudia Altamura
Journal of Neurology, 2023, 270 : 5436 - 5448
[30] Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study
Barbanti, Piero
Aurilia, Cinzia
Torelli, Paola
Egeo, Gabriella
d'Onofrio, Florindo
Finocchi, Cinzia
Carnevale, Antonio
Viticchi, Giovanna
Russo, Marco
Quintana, Simone
Orlando, Bianca
Fiorentini, Giulia
Messina, Roberta
Bartolini, Marco
Pistoia, Francesca
Filippi, Massimo
Bonassi, Stefano
Cevoli, Sabina
Mannocci, Alice
Italian Migraine Registry I GRAINE Study Grp
JOURNAL OF NEUROLOGY, 2025, 272 (02)

← 1 2 3 4 5 →

ULTRA-LATE (&gt;24 WEEKS) RESPONSE TO ANTI-CGRP MONOCLONAL ANTIBODIES IN MIGRAINE: A MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY

ULTRA-LATE (>24 WEEKS) RESPONSE TO ANTI-CGRP MONOCLONAL ANTIBODIES IN MIGRAINE: A MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY